A. J. Pond

Characterization of the V1a antagonist, JNJ-17308616, in rodent models of anxiety-like behavior

R. Hodgson, G. Varty, C. Bleickardt, 2009, Psychopharmacology.

SCH 57790, a selective muscarinic M(2) receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals.

G. Carey, R. Watkins, V. Coffin, 2001, European journal of pharmacology.

Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species

Walter A. Korfmacher, D. Tulshian, R. Hodgson, 2005, Psychopharmacology.

The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles

R. Bertorelli, R. Hodgson, G. Higgins, 2005, Psychopharmacology.

Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression

R. Hodgson, G. Higgins, E. Parker, 2007, Pharmacology Biochemistry and Behavior.

Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders

L. Grégoire, B. Neustadt, A. Stamford, 2010, Experimental Neurology.

The effect of caffeine to increase reaction time in the rat during a test of attention is mediated through antagonism of adenosine A2A receptors

R. Hodgson, G. Higgins, G. Varty, 2007, Behavioural Brain Research.

The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates

R. Hodgson, J. Hunter, E. Parker, 2008, Psychopharmacology.